網(wǎng)站標(biāo)題

搜索

取消

清空記錄

歷史記錄

清空記錄

歷史記錄

清空記錄

歷史記錄

當(dāng)前位置：

產(chǎn)品中心

血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體

該抗體是針對(duì)VEGFC的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFC。

參數(shù)品牌：云克隆

產(chǎn)品參數(shù)

品牌：云克隆

型號(hào)：PAA145Hu01

起訂量：1

規(guī)格:：100ul

價(jià)格:：￥983

我知道了

15906629305

在線客服

客服一

產(chǎn)品詳情

血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體

Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

編號(hào)PAA145Hu01
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
來(lái)源多抗制備
宿主兔
效價(jià)-
Ig類型IgG
純化方式抗原特異性親和純化
標(biāo)記物無(wú)標(biāo)記物
免疫原RPA145Hu01-血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
性狀液體
濃度500μg/mL
且適物種Mus musculus (Mouse，小鼠)
應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。
下載英文說(shuō)明書中文說(shuō)明書
規(guī)格20μl100μl 200μl 1ml 10ml
價(jià)格￥ 983

特異性

該抗體是針對(duì)VEGFC的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFC。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有明顯的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Journal of Cellular Biochemistry	Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443]
genetics and molecular research	Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824]
Experimental and Therapeutic	Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498]
Am J Pathol	IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451]
PLoS One.	Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632]
Oncology Letters	RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo. [pubmed:27895746]
Angiogenesis	Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235]
Oncology Reports	Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465]
LABORATORY INVESTIGATION	Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289]
Cutaneous and Ocular Toxicology	Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957]

血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體

該抗體是針對(duì)VEGFC的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFC。

品牌：云克隆

型號(hào)：PAA145Hu01

起訂量：1

規(guī)格:：100ul

價(jià)格:：￥983

15906629305

在線客服

客服一

產(chǎn)品詳情

血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體

Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)

VEGF-C; Flt4-L; VRPL; Vascular Endothelial Growth Factor-Related Protein

編號(hào)PAA145Hu01
物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
來(lái)源多抗制備
宿主兔
效價(jià)-
Ig類型IgG
純化方式抗原特異性親和純化
標(biāo)記物無(wú)標(biāo)記物
免疫原RPA145Hu01-血管內(nèi)皮生長(zhǎng)因子C(VEGFC)重組蛋白
緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
性狀液體
濃度500μg/mL
且適物種Mus musculus (Mouse，小鼠)
應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。
下載英文說(shuō)明書中文說(shuō)明書
規(guī)格20μl100μl 200μl 1ml 10ml
價(jià)格￥ 983

特異性

該抗體是針對(duì)VEGFC的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VEGFC。

用法

Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。

穩(wěn)定性

參考文獻(xiàn)

雜志	參考文獻(xiàn)
Journal of Cellular Biochemistry	Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma [PubMed: 19241443]
genetics and molecular research	Expression of COX-2 and VEGF-C in cholangiocarcinomas at different clinical and pathological stages [PubMed: 26125824]
Experimental and Therapeutic	Fenofibrate inhibits the expression of VEGFC and VEGFR-3 in retinal pigmental epithelial cells exposed to hypoxia [PubMed: 26622498]
Am J Pathol	IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages [PubMed: 26608451]
PLoS One.	Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells. [pubmed:27383632]
Oncology Letters	RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth andinduces apoptosis in mouse breast cancer in vitro and in vivo. [pubmed:27895746]
Angiogenesis	Characterization of isolated liver sinusoidal endothelial cells for liver bioengineering [Pubmed:29582235]
Oncology Reports	Effects of diphyllin as a novel V-ATPase inhibitor on TE-1 and ECA-109 cells [Pubmed:29328465]
LABORATORY INVESTIGATION	Dynamic signature of lymphangiogenesis during acute kidney injury and chronic kidney disease [Pubmed: 31019289]
Cutaneous and Ocular Toxicology	Isotretinoin does not alter VEGF-A and VEGF-C levels: Do retinoids behave differently in dose-dependent and/or in vivo/in vitro conditions? [Pubmed: 32722957]